The month of May was bustling in the cannabis space. During that time, the Investing News Network (INN) covered the introduction of new cannabis brands from Organigram Holdings (TSXV:OGI) and National Access Cannabis (TSXV:META) as part of the larger branding strategy seen in the industry.

Other big news came on May 15, when CannTrust Holdings (TSX:TRST) increased its production expectations for its new Niagara Greenhouse facility as part of its 2018 first-quarter financial and operational results. The licensed producer (LP) reported revenue of over C$7.8 million and now believes its facility will be capable of delivering 50,000 kilograms of cannabis per year.

In the video above, INN brings investors in the cannabis space an update on some of the biggest developments in the public markets during the month of May. Watch for more insight on what happened in the public space last month.

In a blockbuster deal similar to the CanniMed acquisition, Aurora Cannabis (TSX:ACB) revealed the details of a purchase for MedReleaf (TSX:LEAF), a respected and up until recently medically focused cannabis LP. The deal was inked at a reported C$3.2 billion and will expand production capacity for Aurora.

On the consolidation activity seen so far this year in the space, Aaron Salz, CEO of Stoic Advisory, a firm working with cannabis companies on corporate finance, told INN that some of the driving forces behind M&A activity are “some of the larger companies attempting to extend their reach.”

Salz spoke to INN at the Lift & Co. Expo in Toronto about the future for middle and small companies in the public market and what new investors should keep in mind when entering the volatile space. Watch the interview below for more on what Salz had to say.

As a last highlight during the month of May, INN reported on increasingly bullish sentiment, expressed by an investing panel during Lift, towards US-focused companies raising capital through the Canadian Securities Exchange (CSE), the only Canadian public exchange allowing these companies to do so.

Barrington Miller, director of listed company services for the CSE, told INN he sees the increased potential of the US government to address the status of the drug on a federal level as the cause for this newfound interest in the stocks.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less

It’s been just over a year since recreational cannabis was legalised in the Australian Capital Territory (ACT), home to the nation’s capital city of Canberra.

Announced on September 25, 2019, and brought into effect on January 31, 2020, the rules make it legal to possess and personally use small amounts of cannabis.

Keep reading... Show less

Pac Roots Cannabis Corp. (CSE: PACR) (“PacRoots” or the “Company”), announces the closing of its previously announced non-brokered private placement (see press release dated January 25, 2021).

Aggregate gross proceeds of $1,340,685.90 were raised through the issuance of 7,448,255 units (each a “Unit”). Each Unit consists of one common shares and one share purchase warrant. Each warrant is exercisable at a price of $0.30 per share until February 23, 2024.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its fourth quarter 2020 financial results on Tuesday, March 23, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 7066881. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until March 30, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 7066881.

Keep reading... Show less